INDICAID COVID-19 Antigen Rapid Test FDA EUA HSA/FSA Eligible

Description

Product Overview

The INDICAID COVID-19 Antigen Rapid Test is a compact, over‑the‑counter diagnostic kit designed for quick and accurate detection of SARS‑CoV‑2 antigens at the point of need. Each individual pack contains two self‑contained test devices, a sterile shallow nasal swab, a collection tube, and a clear, step‑by‑step instruction sheet. The test utilizes a lateral flow immunoassay technology that captures viral nucleocapsid proteins from a simple nasal sample and produces a visual result within fifteen minutes. The kit is FDA Emergency Use Authorized, meaning it meets stringent performance criteria for sensitivity and specificity while offering the convenience of home or workplace administration. Its packaging dimensions of 7.99 × 2.6 × 1.06 inches and lightweight 1.76‑ounce design make it easy to store in a drawer, travel bag, or first‑aid kit. The product is HSA/FSA eligible, allowing users to claim reimbursement through qualified health savings accounts, adding a financial benefit to its clinical utility.

Usage

This rapid antigen test is intended for individuals aged two years and older. For users 15 years and older, the test can be self‑administered, while children between two and fourteen years should have an adult assist with sample collection. The testing procedure requires a shallow nasal swab—no deep nasopharyngeal insertion—making it comfortable for repeated use. After collecting the sample, the swab is placed into the provided extraction buffer, mixed, and then applied to the test cassette. Results appear as a colored line in the control region and, if positive, a line in the test region. The clear visual readout eliminates the need for a smartphone app or external reader, simplifying the workflow for schools, workplaces, travel groups, and households.

Because the test is authorized for both home and professional settings, it is ideal for a variety of real‑world scenarios: routine screening before travel, quick verification in a workplace before shift changes, periodic testing in schools to maintain safe in‑person learning, and personal health monitoring during periods of high community transmission. The extended 15‑month shelf life, granted by the FDA in January 2023, ensures that bulk purchasers—such as small businesses, community health programs, and event organizers—can stock the product for longer periods without waste.

Why Choose Us

INDICAID has sold over 45 million tests across more than 30 countries, establishing a reputation for reliability and precision. The company’s commitment to quality is reflected in its rigorous manufacturing processes, which adhere to ISO‑13485 standards for medical device production. Each batch undergoes independent verification to confirm that the limit of detection meets or exceeds the FDA’s requirements for antigen tests. This dedication to accuracy translates into a low false‑negative rate, giving users confidence in the result.

Beyond performance, INDICAID prioritizes user experience. The test’s design eliminates complex steps; the entire process can be completed in four straightforward actions: sample collection, mixing, application, and result reading. The clear, illustrated instructions reduce the likelihood of user error, and the result window is engineered to provide an unmistakable visual cue. Moreover, the product’s eligibility for HSA/FSA reimbursement reduces out‑of‑pocket costs, making it a financially sensible choice for individuals and organizations alike.

Environmental considerations are also part of the product’s value proposition. The packaging uses recyclable materials where possible, and the test components are manufactured with minimal plastic waste. INDICAID’s supply chain incorporates sustainable sourcing practices, aligning the product with the growing demand for eco‑friendly healthcare solutions.

Key Features

• FDA Emergency Use Authorized for rapid, reliable COVID‑19 detection at home or work
• HSA/FSA eligible, allowing users to claim health‑account reimbursement
• Simple shallow nasal swab eliminates discomfort and reduces sampling error
• Results appear in 15 minutes with a clear visual readout—no app required
• Dedicated customer support team provides assistance and guidance for any testing question

FAQ

How accurate is the INDICAID COVID‑19 Antigen Rapid Test?

The test meets FDA performance standards for antigen detection, offering high sensitivity for individuals with moderate to high viral loads and a specificity that minimizes false‑positive results. Clinical studies have demonstrated reliable performance across a range of variants.

Can I use the test if I have received a COVID‑19 vaccine?

Yes. The antigen test detects viral proteins regardless of vaccination status. It is useful for confirming infection when symptoms appear or after exposure, even if you are fully vaccinated.

What is the recommended storage condition for the test kits?

Store the kits at room temperature, between 68°F and 77°F (20°C‑25°C), away from direct sunlight and moisture. The extended shelf life of 15 months ensures the product remains effective when stored properly.

How do I interpret a negative result?

A negative result shows only the control line in the test window. If you have symptoms or a known exposure, consider retesting after 24‑48 hours or consult a healthcare professional for a confirmatory PCR test.

Is the test suitable for children?

Yes. The test is approved for individuals aged two years and older. Children under 15 should have an adult assist with sample collection to ensure proper technique.